NIH-funded research R01 grant

How to keep tobacco cessation programs running at cancer centers

Official title: Sustainability of Tobacco Cessation Programs at NCI-Designated Cancer Centers

Funded at University of Florida · NIH-10879054 · Data updated 2026-11-12

This study is looking at how to keep tobacco quitting programs going strong at cancer centers, so that cancer survivors can have better health outcomes, and it aims to find out what helps these programs succeed in the long run.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Florida
NIH-funded
Lab location1 site (Gainesville, United States)
Project startJuly 1, 2023
Project endJune 30, 2028
Funding year2024
Award (this year)$513,166
NIH project number5R01CA279890-02
Project IDNIH-10879054 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are cancer survivors who smoke and are seeking support to quit smoking.

Less likely to help

Patients who have never smoked or are not interested in quitting smoking may not receive any benefit from this research.

What this research studies

This research investigates how to sustain tobacco cessation programs at cancer centers, which are crucial for improving health outcomes for cancer survivors. It focuses on understanding the factors that contribute to the long-term success of these programs, which are often not consistently integrated into cancer care despite their proven benefits. By analyzing data from various cancer centers, the research aims to develop a model that can be applied broadly to ensure these programs remain effective over time.

Why it matters

Potential benefit: If successful, this research could lead to more effective and sustainable tobacco cessation programs, ultimately improving survival rates and quality of life for cancer survivors.

How similar studies have gone: Previous initiatives have shown success in implementing tobacco cessation programs in cancer care, but this research aims to address the sustainability of such programs, which remains less explored.

Where this research is happening

  • University of Florida
    Gainesville, United States
    Active

Researchers

  • Principal investigator: Salloum, Ramzi George — University of Florida
  • Study coordinator: Salloum, Ramzi George

Related research

Other NIH-funded projects on the same topics.

  • Mitochondrial pores and muscle loss in cancer cachexia

    A small US-based study will explore how changes in mitochondria contribute to muscle wasting in people with cancer cachexia and how this may be slowed.

    NIH research University of Florida · Gainesville, United States · NIH-11636110

  • Photobiomodulation for jaw pain from TMD

    A clinician-scientist at the University of Florida is testing a light-based therapy to help adults with temporomandibular disorder pain feel better and jaw function improve.

    NIH research University of Florida · Gainesville, United States · NIH-11635590

  • How the brain controls swallowing and airway protection

    A research team at the University of Florida is studying how brain networks control swallowing to reduce risk of choking and lung infections in people with neuromuscular diseases.

    NIH research University of Florida · Gainesville, United States · NIH-11630949

  • Donor-driven 3D organoid platform to study pancreatic cancer drug response

    A pilot project to create patient-derived, 3D organoid models of pancreatic cancer to measure how tumors from different people respond to chemotherapy.

    NIH research University of Florida · Gainesville, United States · NIH-11625599

  • RAAS inhibitors and pancreatic cancer risk in diverse adults

    A Florida-based study will look at whether commonly used blood pressure medicines (RAAS inhibitors) are linked to new cases of pancreatic cancer, especially among Black and Hispanic adults.

    NIH research University of Florida · Gainesville, United States · NIH-11625597

  • Pilot project exploring new cancer drugs for pancreatic cancer in African American patients

    A small, early-stage project tests new drug-derived compounds to treat pancreatic cancer, focusing on African American patients who are disproportionately affected.

    NIH research University of Florida · Gainesville, United States · NIH-11625594

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.